Moderate hypofractionated radiotherapy with volumetric modulated arc therapy and simultaneous integrated boost for pelvic irradiation in prostate cancer-Reference-Cited by-同舟云学术

Moderate hypofractionated radiotherapy with volumetric modulated arc therapy and simultaneous integrated boost for pelvic irradiation in prostate cancer

Published:2017-03-08 Issue:7 Volume:143 Page:1301-1309
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Franzese C.,Fogliata A.,D’Agostino G. R.,Di Brina L.,Comito T.,Navarria P.,Cozzi L.,Scorsetti M.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/article/10.1007/s00432-017-2375-9/fulltext.html

Reference39 articles.

1. Arcangeli S, Saracino B, Grazia M et al (2007) Analysis of toxicity in patients with high risk prostate cancer treated with intensity- modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area. Radiother Oncol 84:148–155

2. Arcangeli G, Fowler J, Gomellini S et al (2011) Acute and late toxicity in a randomized trial of conventional versus hypofractionated three-dimensional conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 79:1013–1021

3. Bayley A, Rosewall T, Craig T et al (2010) Clinical application of high-dose, image-guided intensity-modulated radiotherapy in high-risk prostate cancer. Int J Radiat Oncol Biol Phys 77:477–483

4. Chung HT, Xia P, Chan LW et al (2009) Does image-guided radio- therapy improve toxicity profile in whole pelvic-treated high- risk prostate cancer? Comparison between IG-IMRT and IMRT. Int J Radiat Oncol Biol Phys 73:53–60

5. Cury FL, Hunt D, Roach M 3rd et al (2013) Prostate-specific antigen response after short-term hormone therapy plus external-beam radiotherapy and outcome in patients treated on Radiation Therapy Oncology Group study 9413. Cancer 119(11):1999–2004

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancer;Clinical and Translational Radiation Oncology;2024-01

2. Meta-analysis of Elective Pelvic Nodal Irradiation Using Moderate Hypofractionation for High-Risk Prostate Cancer;International Journal of Radiation Oncology*Biology*Physics;2022-08

3. Dosimetric feasibility of moderately hypofractionated/dose escalated radiation therapy for localised prostate cancer with intensity-modulated proton beam therapy using simultaneous integrated boost (SIB-IMPT) and impact of hydrogel prostate-rectum spacer;Radiation Oncology;2022-04-01

4. Radiomics-based prognosis classification for high-risk prostate cancer treated with radiotherapy;Strahlentherapie und Onkologie;2022-01-21

5. Long-term safety of high-dose whole pelvic IMRT for high-risk localized prostate cancer through 10-year follow-up;International Journal of Clinical Oncology;2021-08-02